Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2025)

Rapid Micro Biosystems has disclosed Asset Writedowns and Impairment across 5 years of filings, most recently posting $1.1 million for Q4 2025.

• Asset Writedowns and Impairment for Q4 2025 came in at $1.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $908000.0 (up 175.15% YoY), and the FY2025 annual result was $1.1 million, up 1103.16% from the prior year.
• Asset Writedowns and Impairment came in at $1.1 million for Q4 2025 at Rapid Micro Biosystems, up from -$216000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $1.1 million in Q4 2025 to a low of -$216000.0 in Q2 2025.
• The 5-year median for Asset Writedowns and Impairment is $72000.0 (2022), against an average of $162000.0.
• Across the five-year window, Asset Writedowns and Impairment soared 2733.33% in 2022 and plunged 327.37% in 2025, its largest moves.
• Rapid Micro Biosystems' Asset Writedowns and Impairment stood at $16000.0 in 2021, then soared by 568.75% to $107000.0 in 2022, then sank by 68.22% to $34000.0 in 2023, then surged by 179.41% to $95000.0 in 2024, then jumped by 1083.16% to $1.1 million in 2025.
• The last three Asset Writedowns and Impairment figures came in at $1.1 million (Q4 2025), -$216000.0 (Q2 2025), and $235000.0 (Q1 2025), per Business Quant data.